Animal Models of Secondary Lymphedema: New Approaches in the Search for Therapeutic Options

被引:30
|
作者
Hadrian, Rebecca [1 ]
Palmes, Daniel [1 ]
机构
[1] Univ Hosp Munster, Dept Gen & Visceral Surg, Munster, Germany
关键词
secondary lymphedema; animal models; microsurgery; VEGF-C; LYMPHO-LYMPHONODULAR ANASTOMOSES; NODE FRAGMENTS; BREAST-CANCER; MOUSE TAIL; RAT MODEL; LYMPHANGIOGENESIS; TRANSPLANTATION; VESSEL; REGENERATION; AUGMENTS;
D O I
10.1089/lrb.2016.0015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Secondary lymphedema is still a worldwide problem. Symptomatic approaches to lymphedema therapy have been mainly used, with complete decongestive therapy as the cornerstone. Due to a lack of regenerative therapy, researchers have established various animal models to obtain insights into pathomechanisms and to reveal the best therapeutic option. Since the first reproducible and reliable animal model of lymphedema was reported in dogs, the technique of circumferential excision of lymphatic tissue has been translated mainly to rodents to induce secondary lymphedema. In these models, various promising pharmacological and surgical approaches have been investigated to improve secondary lymphedema therapy. Imaging modalities are crucial to detect the extent of lymphatic dysfunction and decide the best therapy. The gold standard of lymphoscintigraphy is currently limited by poor spatial resolution and lack of quantification. Animal models could help to bridge a gap in improving morphological correlation and quantifying lymphatic functionality. This review summarizes the animal models used in lymphatic research and focuses on new therapeutic options and requirements for imaging modalities to visualize the lymphatic system.
引用
收藏
页码:2 / 16
页数:15
相关论文
共 50 条
  • [21] Use of Integrated Computational Approaches in the Search for New Therapeutic Agents
    Persico, Marco
    Di Dato, Antonio
    Orteca, Nausicaa
    Cimino, Paola
    Novellino, Ettore
    Fattorusso, Caterina
    MOLECULAR INFORMATICS, 2016, 35 (8-9) : 309 - 325
  • [22] Study on the Therapeutic Efficacy of a Polyphitho Therapeutic Compound in Primary and Secondary Lymphedema
    Michelini, Sandro
    Gasbarro, Vincenzo
    Izzo, Marcello
    Albergati, Francesco G.
    LYMPHATIC RESEARCH AND BIOLOGY, 2021, 19 (01) : 66 - 72
  • [23] Primary and secondary lymphedema: priority in therapeutic strategies.
    Michelini, S.
    Cardone, M.
    Failla, A.
    Moneta, G.
    Fiorentino, A.
    Cappellino, F.
    17TH ESPRM EUROPEAN CONGRESS OF PHYSICAL AND REHABILITATION MEDICINE, 2010, : 189 - 190
  • [24] New possibilities in the pathogenesis of secondary lymphedema
    Hall, JG
    LYMPHOLOGY, 2002, 35 (03) : 129 - 129
  • [25] Inhalation toxicology of ricin preparations: Animal models, prophylactic and therapeutic approaches to protection
    Griffiths, Gareth D.
    Phillips, Gary J.
    Holley, Jane
    INHALATION TOXICOLOGY, 2007, 19 (10) : 873 - 887
  • [26] MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches
    Bridget Martinez
    Philip V.Peplow
    Neural Regeneration Research, 2022, 17 (04) : 728 - 740
  • [27] Therapeutic approaches of trophic factors in animal models and in patients with spinal cord injury
    Diaz-Galindo, Maria del Carmen
    Calderon-Vallejo, Denisse
    Olvera-Sandoval, Carlos
    Quintanar, J. Luis
    GROWTH FACTORS, 2020, 38 (01) : 1 - 15
  • [28] Novel Therapeutic Approaches to Lupus Glomerulonephritis: Translating Animal Models to Clinical Practice
    Bagavant, Harini
    Kalantarinia, Kambiz
    Scindia, Yogesh
    Deshmukh, Umesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (03) : 498 - 507
  • [29] MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches
    Martinez, Bridget
    Peplow, Philip, V
    NEURAL REGENERATION RESEARCH, 2022, 17 (04) : 728 - 740
  • [30] Animal models for personalized treatment options
    Fichtner, Iduna
    Klinghammer, Konrad
    Behrens, Diana
    Flechsig, Susanne
    Rolff, Jana
    Becker, Michael
    Wulf-Goldenberg, Annika
    Stecklum, Maria
    Rivera, Maria
    Brzezicha, Bernadette
    Jandrig, Burkhard
    Hoffmann, Jens
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (08) : 698 - 700